In this week's edition, Break Through Cancer awards $50M to fund a 'radical collaboration' in cancer research; the FDA grants a breakthrough device designation for an MS plasma test; App-based mental exercises may improve cognitive impairment; and more.
Read the full coverage here:
Break Through Cancer awards $50M to fund 'radical collaboration' in cancer research
FDA grants breakthrough device designation for MS plasma test
App-based mental exercises improve cognitive impairment
Neurodevelopment in infants with CHD may be predicted in utero
Benefits of ticagrelor, aspirin for stroke outweigh risks over 30 days
References:
Press Release
Healio Interview
Wang Y, et al. Neurology. 2022;doi:10.1212/WNL.0000000000200355.
